Condition: Syphilis Infection · Gonorrhea · Chlamydia · Sponsor: Bangrak STIs Center
The objective of this research is to evaluate the efficacy and safety of doxycycline in MSM for preventing sexually transmitted infections (gonorrhea, chlamydia, and syphilis) in Thailand Participation in this study will last approximately 12 weeks and will include 2-3 clinic visits, along with 10-11 follow-up phone contacts over a period of 11 weeks.
This description comes directly from the study's public registry record.
Rossapnorn Kittiyaowamarn, MD · +66814501066 · rossaphorn@gmail.com
Kittipoom Chinhiran, MD · +66863583077 · x_destiny_war@hotmail.com
Always discuss trial participation with your own doctor first.
| Bangrak STIs Center | Sathorn, Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07397403